Samplix logo

Samplix

Reveal cell function with single-cell resolution.

35 employees · est. 2013 · Denmark

VS
Singleron Biotechnologies logo

Singleron Biotechnologies

From single cell multi-omics to precision medicine

90 employees · est. 2018 · Cologne, Germany

Samplix is the older company (2013 vs 2018); Singleron Biotechnologies is the larger of the two.

Side-by-Side Comparison

Samplix Singleron Biotechnologies
Founded
2013 older 2018
Headquarters
Denmark Cologne, Germany
Employees
35 90 larger
Industry
Biotechnology, Information Technology Biotechnology
Funding Stage
Series Unknown Series B
Total Funding
$12.67M $230.00M
Funding Rounds
3 3
Services
Not tracked yet Single Cell and Single Nucleus Sequencing, Immune Profiling, Bioinformatics Services, eQTL Analysis, Bulk mRNA Sequencing, Single Cell ATAC-seq
Target Customers
Not tracked yet Clinical Researchers, Biopharma Companies, Academic Institutions, Pharmaceutical Companies, Healthcare Professionals
Taxonomy
Single-cell Analysis, Immunotherapy Research, Double Emulsion Technology, Flow Cytometry, Cell Sorting, Xdrop Technology, Living Cells Encapsulation, Reactive Molecules, Microenvironment, Flow Cytometry And Sorting, Engineered Cell Therapy Research, Protein Engineering, Synthetic Biology Workflows, Cell Interaction, Cell Secretion Single Cell Sequencing, Multi-omics, Precision Medicine, Clinical Research, Diagnostics, Drug Development, High-throughput Analysis, Microfluidics, Molecular Diagnosis, Data Sciences, Cancer Research, Health Management, Innovation
Website
samplix.com singleron.bio
Samplix logo

About Samplix

Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technology to encapsulate living cells and reactive molecules in stable droplets, enabling rapid cell-cell...

Singleron Biotechnologies logo

About Singleron Biotechnologies

Singleron Biotechnologies, founded in 2018, is a pioneering name in the Biotechnology industry. With a focus on transforming clinical research, diagnostics, and drug development, Singleron leverages high-throughput single-cell analyses to generate rapid and precise research outcomes. Their innovativ...

We will tell you when either one moves

BounceWatch watches Samplix and Singleron Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Samplix and Singleron Biotechnolog... — by email.

Frequently Asked Questions

Samplix — Reveal cell function with single-cell resolution.. Singleron Biotechnologies — From single cell multi-omics to precision medicine. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Samplix has raised $12.67M while Singleron Biotechnologies has raised $230.00M.
Samplix and Singleron Biotechnologies operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Samplix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Samplix on 12 Sep 2024, and Singleron Biotechnologies on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy